Sanara MedTech (NASDAQ:SMTI) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $0.02 by 350 percent. This is a 78.26 percent increase over losses of $(0.23) per share from the same period last year. The company reported quarterly sales of $28.137 million which missed the analyst consensus estimate of $28.950 million by 2.81 percent. This is a 8.93 percent increase over sales of $25.831 million the same period last year.